BeStock  
Stocks › Biotechnology › ALT

Altimmune ALT

US equityMarket cap rank #3713Biotechnology
$2.08 +$0.11 (+5.58%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $2.07 -0.48%
Open$1.97
Prev close$1.97
Day range$1.95 – $2.10
Volume2.77M
Market cap$404.60M
P/E (TTM)–
Dividend yield–

Average implied volatility across the listed chain right now: 631%. Implied volatility measures how big a price swing the options market is pricing in — there is no fixed “normal” level, it varies a lot by stock.

Open interest by strike

0.501.001.502.002.503.003.504.005.00CallsPuts

Nearest listed expiry only. Calls above the line, puts below — clusters mark strikes where the market has built up the most open positions.

Implied volatility by strike

-49%605%1258%1912%0.502.505.00CallsPuts

The “volatility smile”: strikes far from the current price often price in richer implied volatility than at-the-money strikes.

Calls

ExpiryStrikeLastBid/AskVolumeOpen interestIV
13 Nov 2026 $2.00 $0.15 $0.05/$0.30 8 15 130%
13 Nov 2026 $2.50 $0.01 $0.00/$1.65 0 0 114%
13 Nov 2026 $1.50 $0.55 $0.30/$1.25 10 10 492%
13 Nov 2026 $3.00 $0.00 $0.00/$0.95 0 14 123%
13 Nov 2026 $1.00 $1.09 $0.75/$2.95 3 17 2,266%
13 Nov 2026 $3.50 $0.00 $0.00/$2.15 0 0 134%
13 Nov 2026 $0.50 $1.53 $1.30/$2.35 3 5 1,748%
13 Nov 2026 $4.00 $0.00 $0.00/$1.10 0 10 165%
13 Nov 2026 $5.00 $0.00 $0.00/$1.00 0 0 214%

Puts

ExpiryStrikeLastBid/AskVolumeOpen interestIV
13 Nov 2026 $2.00 $0.15 $0.00/$0.90 0 10 189%
13 Nov 2026 $2.50 $0.54 $0.05/$2.55 0 4 1,025%
13 Nov 2026 $1.50 $0.01 $0.00/$1.15 0 0 161%
13 Nov 2026 $3.00 $1.08 $0.55/$1.80 8 26 501%
13 Nov 2026 $1.00 $0.00 $0.00/$0.05 0 0 248%
13 Nov 2026 $3.50 $1.53 $1.20/$3.60 0 0 1,319%
13 Nov 2026 $0.50 $0.00 $0.00/$0.50 0 0 368%
13 Nov 2026 $4.00 $2.03 $1.60/$2.80 1 0 677%
13 Nov 2026 $5.00 $3.05 $2.70/$5.10 1 0 1,486%

Open interest = contracts currently outstanding (not yet closed out). Higher open interest generally means a strike/expiry is more actively traded and easier to get in and out of.

Discussion

No comments yet — be the first to weigh in on ALT.

Sign in to join the discussion.

Scroll to Top